JP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $26 to $30.
JP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $26 to $30.